Melatonin 1.0 mg Peppermint Flavor
Product analysis
Melatonin 1.0 mg Peppermint Flavor offers a low-cost way to support sleep timing and may help shorten the time it takes to fall asleep. Its usefulness depends on timing and individual sleep patterns.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The precise melatonin form is unspecified, limiting a detailed quality comparison. How well the body can use it cannot be judged confidently.
Ingredient Transparency63
The melatonin amount is stated, making the serving easy to check. Its precise form is unspecified, limiting more detailed comparisons.
Value For Money100
The labeled serving has a low cost compared with the relevant alternatives. The affordable price does not determine whether its timing suits an individual’s sleep pattern.
Customer Satisfaction75
Customer ratings are very favorable, with a modest number of reviews. They offer some insight into satisfaction without proving a sleep benefit.
Product Focus92
Melatonin may support sleep timing and help people fall asleep sooner. The amount aligns with small sleep-onset findings, but does not establish broad relaxation or sustained-sleep benefits.
- Format
Lozenge - Container
- 300 Liquid(s)
- Per serving
- $0.05
- Also available
Melatonin 1.0 mg Orange Flavor$17.85- Customer rating
- 4.8 · 164 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Melatonin | 1 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability0
Third-Party Purity Verification
Dose, Safety & Label Transparency100
Physiological Dosing Alignment
Value100
Price Per Serving Efficiency
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Meta-analysis: melatonin for the treatment of primary sleep disorders.
- Melatonin treatment for age-related insomnia.
- The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
- Effects of exogenous melatonin on sleep: a meta-analysis.